Answers are grounded in this paper and cite their sources.
Longitudinal analysis differentiates NMOSD from MS, suggesting new metrics for disease activity assessment.
Longitudinal reductions in distinct cortical regions may serve as an ideal metric for differentiating NMOSD from MS and may provide evidence of subclinical disease activity.
No takes yet. Share an insight, caveat, or question.
Okuda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: